[CIS PIDD] [cis-pidd] IVIG/ScIg for Complement deficiency?

Nacho Gonzalez nachgonzalez at gmail.com
Tue Apr 14 11:17:54 EDT 2015


The European experience has been recently collected and published this year
in JCI (PMID: 25663093). No patient received IVIG (as has been said, it has
no sense). 68% of them received prophylactic antibiotics (physicians in the
UK were more likely to prescribe antibiotic prophylaxis than colleagues on
the Continent for patients with classical pathway defects). Perhaps Peter
Arkwright (colleagues from Manchester collected the data) may explain
specifically the EU approach concerning C2 def patients. Vaccines are the
cornerstone for the prophylaxis in these patients.

Luis Ignacio Gonzalez Granado
Immunodeficiencies Unit
Pediatrics
Hospital 12 octubre. Madrid. Spain

2015-04-14 16:58 GMT+02:00 Saxon, Andy M.D. <ASaxon at mednet.ucla.edu>:

>  As Joe said, makes no sense.  There is a growing group of less than
> critical folks who are using IVIG (and charging for it through their
> practices) for all sorts of inappropriate diagnoses and making
> “appropriate” diagnoses, e.g. CIDP) with little basis so as to give IVIG as
> a revenue stream.
>
>
>
> How many cases of real C2 deficiency have you got floating around up there
> anyway? And I thought the concern was autoimmunity, not infection in real
> C2 deficiency as opposed to say C8 deficiency. I’d like to hear from some
> of you great Peds folks in addition to the outstanding Joe Church..
>
>
>
> Andy Saxon, MD
>
> Professor of Medicine
>
> UCLA
>
>
>
> PS – Hi Joe!
>
>
>
> *From:* Church, Joseph [mailto:JChurch at chla.usc.edu]
> *Sent:* Tuesday, April 14, 2015 7:51 AM
> *To:* CIS-PIDD
> *Subject:* RE: [cis-pidd] IVIG/ScIg for Complement deficiency?
>
>
>
> This makes no sense to me.  The patients’ problem is not the inability to
> make antibodies, it is the inability to use complement that is activated by
> the classical pathway (or lectin pathway) regardless of the source of
> antibodies.
>
>
>
> Joe Church
>
> Children’s Hospital Los Angeles
>
>
>
> *From:* Jason Raasch [mailto:jraasch at midwestimmunology.com
> <jraasch at midwestimmunology.com>]
> *Sent:* Monday, April 13, 2015 1:31 PM
> *To:* CIS-PIDD
> *Subject:* [cis-pidd] IVIG/ScIg for Complement deficiency?
>
>
>
> Hello everyone.
>
>
> I have heard of some practitioners in our region using IVIG as sole
> management for isolated C2 deficiency in infants/children (i.e. instead of
> prophylactic antibiotics, immunizations for encapsulated organisms, etc.).
> The feeling is long-term use of prophylactic antibiotics in these cases is
> irresponsible.
>
>
>
> I will be honest and admit I have not heard of this before or found much
> in the literature.  What am I missing here?
>
>
>
> I would appreciate any comments.
>
>
>
> Regards,
>
>
>
> Jason
>
>
>
> Jason Raasch, MD
>
> Midwest Immunology Clinic
> 15700 37th Ave N, Ste 110
> Plymouth, MN 55446
>
> TEL: (763) 577-0008
> FAX: (763) 577-0192
>
>
>
>
>
>
>
> ---
>
> You are currently subscribed to cis-pidd as: jchurch at chla.usc.edu.
>
> To unsubscribe click here:
> http://cts.dundee.net/u?id=96396658.df9245d5219d19fc82ac9f3bbf52c836&n=T&l=cis-pidd&o=2754516
>
> (It may be necessary to cut and paste the above URL if the line is broken)
>
> or send a blank email to
> leave-2754516-96396658.df9245d5219d19fc82ac9f3bbf52c836 at lyris.dundee.net
>
>
> ---------------------------------------------------------------------
> CONFIDENTIALITY NOTICE: This e-mail message, including any attachments,
> is for the sole use of the intended recipient(s) and may contain
> confidential
> or legally privileged information. Any unauthorized review, use, disclosure
> or distribution is prohibited. If you are not the intended recipient,
> please
> contact the sender by reply e-mail and destroy all copies of this original
> message.
>
> ---------------------------------------------------------------------
>
> ---
>
> You are currently subscribed to cis-pidd as: asaxon at mednet.ucla.edu.
>
> To unsubscribe click here:
> http://cts.dundee.net/u?id=96396407.796a171b5229f2fd82173d332612cc52&n=T&l=cis-pidd&o=2756700
>
> (It may be necessary to cut and paste the above URL if the line is broken)
>
> or send a blank email to
> leave-2756700-96396407.796a171b5229f2fd82173d332612cc52 at lyris.dundee.net
>
> ------------------------------
>
> IMPORTANT WARNING: This email (and any attachments) is only intended for
> the use of the person or entity to which it is addressed, and may contain
> information that is privileged and confidential. You, the recipient, are
> obligated to maintain it in a safe, secure and confidential manner.
> Unauthorized redisclosure or failure to maintain confidentiality may
> subject you to federal and state penalties. If you are not the intended
> recipient, please immediately notify us by return email, and delete this
> message from your computer.
>
> ---
>
> You are currently subscribed to cis-pidd as: nachgonzalez at gmail.com.
>
> To unsubscribe click here:
> http://cts.dundee.net/u?id=96396812.66aedac07f1044b5f6e7c94e3e51e2ac&n=T&l=cis-pidd&o=2756734
>
> (It may be necessary to cut and paste the above URL if the line is broken)
>
> or send a blank email to
> leave-2756734-96396812.66aedac07f1044b5f6e7c94e3e51e2ac at lyris.dundee.net
>
>

---
You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://cts.dundee.net/u?id=96396833.5a9591ccd1e327fe6bc4d1543298c482&n=T&l=cis-pidd&o=2756814
or send a blank email to leave-2756814-96396833.5a9591ccd1e327fe6bc4d1543298c482 at lyris.dundee.net
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20150414/f4c64663/attachment-0001.html>


More information about the PAGID mailing list